Evaluating the Combined Effect of Oral Premedications on Inferior Alveolar Nerve Block Effectiveness
Status:
COMPLETED
Trial end date:
2024-11-23
Target enrollment:
Participant gender:
Summary
This clinical study investigates whether the combination of ibuprofen and serratiopeptidase as oral premedication can enhance the effectiveness of the inferior alveolar nerve block (IANB) in patients with symptomatic irreversible pulpitis in mandibular teeth. Due to the inflammatory nature of the condition, standard IANB often fails, possibly due to prostaglandin-induced nerve sensitization.
A total of 96 patients meeting specific inclusion criteria will be divided into four groups:
Placebo
Ibuprofen alone
Serratiopeptidase alone
Combination of ibuprofen and serratiopeptidase
Pain levels will be measured using the Verbal Numerical Scale (VNS) at various treatment stages. The success of anesthesia will be determined by the absence or presence of pain during access cavity preparation and initial root canal instrumentation. Statistical analysis will compare the effectiveness between groups, with the goal of determining whether combined premedication significantly improves IANB success.
The study is conducted at the Department of Operative Dentistry \& Endodontics, HITEC-IMS Taxila, over a period of six months.